{"entity":{"id":"nct06255912","kind":"trial","name":"Clinical Trial for Advanced or Metastatic Pancreatic Cancer","aka":[],"tldr":"A phase 2 trial in pancreatic cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, not yet recruiting.","summary":"Clinical Trial for Advanced or Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT06255912 by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, with a registry enrolment figure of 26 participants, started 2024-03-01 and due to reach its primary completion in 2029-03-01. Interventions recorded: LTC004 + MIL-97; LTC004 + MIL-97+chemotherapy. Conditions listed: Pancreas Cancer. Primary outcome: Dose Limiting Toxicity; Maximum tolerated dose Tolerated Dose Dose; Treatment Emergent Adverse Events. Pancreatic eligibility wording from the registry: \"Patients with inoperable advanced pancreatic cancer who have experienced progression during or after receiving at least one systemic treatment line, including the modified FOLFIRINOX regimen, capecitabine and/or gemcitabine, erlotinib, with or without platinum agents (oxaliplatin, cisplatin, or carb\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06255912","url":"https://clinicaltrials.gov/study/NCT06255912"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["locally-advanced-pdac","metastatic-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06255912","phase":"2","setting":"A Phase II Clinical Trial Assessing the Safety, Tolerability, and Pharmacokinetics of LTC004 in Combination With MIL-97 ± Chemotherapy in Patients With Advanced or Metastatic Pancreatic Cancer","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","enrolled":26,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06255912/","neighbours":{"cancer":[{"id":"locally-advanced-pdac","kind":"cancer","name":"Locally advanced unresectable pancreatic ductal adenocarcinoma","route":"/cancers/locally-advanced-pdac/"},{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}